# [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment

> **NCT01633255** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Kidney Neoplasms

## Interventions

- **DRUG:** 18F-Fluciclatide

## Key facts

- **NCT ID:** NCT01633255
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-04-18
- **Primary completion:** 2014-04-23
- **Final completion:** 2014-04-23
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633255, "[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01633255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*